Clinical Trial Update: Tacrolimus Minimization in Kidney Transplant Recipients Selected According to the AGORA Algorithm for Their Low Immunological Risk and Medium-term Graft Failure [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating minimization of tacrolimus in kidney transplant recipients identified as low immunological risk by the AGORA algorithm. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Nantes University Hospital | Conditions: Organ Grafts | Phase 3 | Status: RECRUITING